Comp. Cancer Centers of Nevada

Las Vegas, Nevada 89169

0 studies enrolling now · 3 studies all time

What they study most

Chemotherapeutic Toxicity, Colorectal Cancer Metastatic, Myelosuppression-Adult, Neoplasm Metastasis, Non-Small Cell Lung Cancer

Studies at this site

• A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies — Running, not enrolling
• Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer (mCRC): — Stopped early
• A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS) — Completed